Adult ; Animals ; Bone Density ; Calcium Sulfate ; Depression ; Dogs ; Golgi Apparatus ; Humans ; Organelles ; Osteoblasts ; Osteogenesis ; Secretory Vesicles ; Transplants ; Wounds and Injuries

OBJECTIVE: The aim of this study was to determine clinical significance of weight difference in twin pregnancies. METHODS: The medical records of 157 sets of twin pregnancies delivered between 1992 and 2001 were reviewed retrospectively. Birth weight differences were stratified 3 categries; 15% or less, 16-30%, 31%, or more. x2 stastics and ANOVA was used. RESULTS: The degree of difference correlated strongly with risk for SGA, RDS, Sepsis, Length of hospital stay, congenital anomaly, perinatal mortality but there were no increment in PDA and preterm delivery. There were no differences in outcomes for the smaller compared with larger twin of the twin pair. Maternal complications such as preeclampsia was increased in weight discordant twin. CONCLUSION: Twin birth weight difference was closely related to adverse perinatal outcome. In severe intrapair weight difference (31% or more), all cases showed fetal death, which means physicians need to consider pregnancy termination. Birth weight discordance was a very complex problem. In the management of discordant twin, more frequent antenatal care and closer observation was recommended.
Birth Weight* ; Fetal Death ; Humans ; Length of Stay ; Medical Records ; Parturition* ; Perinatal Mortality ; Pre-Eclampsia ; Pregnancy ; Pregnancy, Twin ; Retrospective Studies ; Sepsis

Propofol is an intravenous hypnotic agent that is generally used for sedation in the intensive care unit and for induction of anesthesia during minimally invasive surgery, endoscopy, and plastic surgery in local clinics. Low blood pressure and transient apnea might occur under propofol sedation, whereas stress-induced cardiomyopathy is a very rare complication. We herein describe a case involving a 25-year-old woman without cardiovascular risk factors who developed stress-induced cardiomyopathy after propofol injection for anesthesia and was treated with conservative treatment. This case reminds us that clinicians should consider the possible occurrence of stress-induced cardiomyopathy after anesthesia using propofol, even in patients without cardiovascular risk factors.
Adult ; Anesthesia* ; Apnea ; Cardiomyopathies* ; Endoscopy ; Female ; Humans ; Hypotension ; Intensive Care Units ; Propofol* ; Risk Factors ; Surgery, Plastic ; Surgical Procedures, Minimally Invasive

BACKGROUND: BRCA1 (breast-cancer gene 1) is a tumor suppressor gene that accounts for nearly all families of both early onset breast and ovarian cancer and about 45% of families with breast cancer only. Sporadic nonhereditary breast cancer is recognized as the most common form of this malignancy. However, presence of germ-line mutations in the BRCA1 gene of these tumors is an infrequent event. The BRCA1 protein includes a ring domain and an acidic domain, both of which are characteristics of certain transcription factors, as well as two putative nuclear localization signals (NLS) that interact with importin-alpha. The normal BRCA1 protein is located in the nucleus of most breast-cell types whereas the BRCA1 protein of breast cancer cells is aberrantly localized in the cytoplasm. This mislocation of the BRCA1 protein in breast cancer cells may be due to defects in the NLS receptor-mediated pathway for the nuclear import of the BRCA1 gene product. Identification of importin-alpha mutations as a cellular protein responsible for the nuclear import of BRCA1 in breast-cancer cell lines and primary breast cancers is the focus of this investigation. METHODS: A series of 15 surgical samples of breast cancer and 3 samples of breast-cancer cell lines (Hs578T, ZR75-1, MCF-7) was assayed for the presence of the deletion mutant in importin-alpha by using both RT-PCR amplification of importin-alpha transcripts and sequencing analysis. RESULTS: Three of the 15 primary breast cancers and 1 of the 3 breast-cancer cell lines showing deletions in importin-alpha transcripts produced two different truncated transcripts. 1208 bp deletions were observed in transcripts from breast cancer (T-1, T-3) and ZR75-1, which is specified by the nucleotide 251-1458 of the transcript. Another transcript encoded by primary breast cancer (T-2) included a 1312 bp deletion in the nucleotide 61-1372 of the transcript. CONCLUSIONS: The deletions eliminated part of the importin-alpha transcript segment encoding the putative NLS-binding domain but not the importin-beta binding domain, suggesting that these deletion mutants could not bind to NLS of the BRCA1 protein. These results suggest that the composite effects of mislocationof the BRCA1 protein by deletion of the NLS-binding domain in importin-alpha may contribute to tumorigenesis in sporadic breast cancer.
Active Transport, Cell Nucleus ; alpha Karyopherins* ; Alternative Splicing ; beta Karyopherins ; BRCA1 Protein ; Breast Neoplasms* ; Breast* ; Carcinogenesis ; Cell Line ; Cytoplasm ; Genes, BRCA1 ; Genes, Tumor Suppressor ; Germ-Line Mutation ; Humans ; Nuclear Localization Signals ; Ovarian Neoplasms ; Transcription Factors